+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Report on China’s Anti-Asthma Drug Market

  • ID: 45955
  • Report
  • November 2004
  • Region: China
  • 10 Pages
  • Sunfaith China Ltd
1 of 4
The report first analyzes the occurrences of the asthma in China, pointing out that the market space for the anti-asthma drugs is fairly large due to its high incidence, huge number of affecters and serious harm. It then gives a general description on China’s anti-asthma drug market. In the hospital market, Western medicines such as the Anti-Inflammatory drugs take a large market share, whereas in the OTC market, the sales of the Chinese traditional medicines are higher.

The report points out that hormone inhaler has always been the most important drug in the whole anti-asthma drug market, however, in recent years, its market share is in the declining trend. The market share of Adrenocept inhaler, following the hormone inhaler in the market share, has enjoyed a rapid growth because of its unsubstutional position in easing acute symptom.

The report analyzes some famous brands of China’s anti-asthma drugs on the basis of a group of statistics. Foreign drugs take the prominent role in this market. The report lays emphasis on the centralization of this market.
Note: Product cover images may vary from those shown
2 of 4


3 of 4
Executive Summaries

1. Brief introduction
1.1 Asthma and the drugs.
1.2 Forecast on the market scale

2. Analysis on the sorts of anti-asthma drugs

3. Analysis on the drug application in China’s main metropolises

4. Summaries
Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown